Back to Trades
Mack Gene
CEOPresidentDirectorCIK 0001737979
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Mack Gene, CEO, President, Director, has disclosed $372.0K in transactions — all concentrated in Gain Therapeutics, Inc. (GANX). Data is sourced from official SEC Form 3, 4, and 5 filings.